• Home
  • About us
  • Log-In
  • Join Us
  • Sitemap
  • Recruit
제품/실험 Q&A
자주묻는질문
자유게시판
실험기법
자료신청
논문자료
클레임 접수
기기 A/S 접수
클레임 진행조회
 제품안내  신경약학   Compound Collection

Tocriset™

Tocriset™은 pharmacological이나 signaling area 내의 compound를 소량씩 모아 제공하는 "Miniature compound set"입니다.

TOCRIS
제품 문의하기
인쇄하기

    특징
  • 각 set별로 5가지의 compound를 소량씩 제공하기 때문에, 다량으로 구매할 필요가 없이 경제적입니다.
  • lyophilized solid의 경우, 1-2mg로 freeze-drying되어 있어 용매만 첨가함으로써 stock solution을 제작 할 수 있습니다.
  • lyophilized solid형태로 적합하지 않은 compound는 미리 용해된 상태로 제공되므로 바로 사용할 수 있습니다.
  • 자세한 solubility instruction, 적합한 용매, 제품안내 및 참고자료는 제품과 함께 제공되는 매뉴얼에 기록되어 있습니다.
    사양
  • 제품 구성
    • Signal Transduction
      Cat. No. Product Components
      Name Function Cat. No.
      1878 MAPK Cascade Inhibitor Tocriset™ Genistein epidermal growth factor receptor (EGFR) kinase inhibitor 1110
      PD 98059 specific inhibitor of MAPKK/MEK 1213
      ZM 336372 potent, selective c-Raf inhibitor 1321
      U0126 potent, selective inhibitor of MEK1 and 2 1144
      SB 203580 selective inhibitor of p38 MAPK 1202
      1879 MAPK Inhibitor Tocriset™ PD 98059 specific inhibitor of MAPKK/MEK 1213
      SB 203580 selective inhibitor of p38 MAPK 1202
      SB 202190 potent, selective inhibitor of p38 MAPK 1264
      SP 600125 selective JNK inhibitor 1496
      U0126 potent, selective inhibitor of MEK1 and 2 1144
      1880 Mixed Kinase Inhibitor Tocriset™ GF 109203X selective inhibitor of PKC 0741
      KN-62 selective inhibitor of CaM kinase II 1277
      KT 5720 potent, selective inhibitor of PKA 1288
      KT 5823 highly selective inhibitor of PKG 1289
      Staurosporine broad spectrum protein kinase inhibitor 1285
      1881 Phosphodiesterase Inhibitor Tocriset™ Cilostamide selective inhibitor of PDE3 0915
      Milrinone potent inhibitor of PDE3 1504
      Ro 20-1724 widely used PDE inhibitor, selective for PDE4 0415
      (R)-(-)-Rolipram selective inhibitor of PDE4 1349
      Zardaverine selective inhibitor of PDE3 and 4 1046
      1882 PKA Tocriset™ cAMPS-Rp, triethylammonium salt competitive antagonist of cAMP-induced PKA activation 1337
      8-Bromo-cAMP, sodium salt cell-permeable cAMP analogue; PKA activator 1140
      Forskolin cell-permeable activator of adenylyl cylcase 1099
      KT 5720 potent, selective inhibitor of PKA 1288
      NKH 477 water-soluble analogue of forskolin; activator of adenylyl cyclase 1603
    • Glutamatergics
      Cat. No. Product Components
      Name Function Cat. No.
      Ionotropic
      1822 AMPA Receptor Tocriset™ (S)-AMPA specific agonist 0254
      (S)-(-)-5-Fluorowillardiine selective AMPA agonist 0306
      NBQX disodium salt selective AMPA antagonist 1044
      Cyclothiazide AMPA receptor desensitization inhibitor 0713
      GYKI 52466 hydrochloride AMPA/kainate receptor antagonist 1454
      1823 NMDA Receptor-Glycine Site Tocriset™ Glycine endogenous potentiator 0219
      (R)-(+)-HA-966 partial agonist 0281
      L-689,560 glycine site NMDA antagonist 0742
      CGP 78608 hydrochloride glycine site NMDA antagonist 1493
      7-Chlorokynurenic acid glycine site NMDA antagonist 0237
      1824 Kainate Receptor Tocriset™ ATPA selective GluR5 agonist 1107
      Kainic acid selective agonist 0222
      SYM 2081 selective ligand 0903
      CNQX disodium salt AMPA/kainate receptor antagonist 1045
      GYKI 52466 hydrochloride AMPA/kainate receptor antagonist 1454
      1825 Mixed NMDA Receptor Tocriset™ NMDA specific NMDA agonist 0114
      (RS)-(Tetrazol-5-yl)glycine potent NMDA agonist 0312
      D-AP5 potent, selective NMDA antagonist 0106
      (+)-MK 801 maleate non-competitive NMDA antagonist 0924
      CGS 19755 NMDA antagonist 1241
      Metabotropic
      1826 Group I mGlu Receptor Tocriset™ (S)-3,5-DHPG specific group I mGlu agonist 0805
      L-Quisqualic acid potent group I mGlu agonist 0188
      LY 367385 selective mGlu1a antagonist 1237
      MPEP hydrochloride selective mGlu5 antagonist 1212
      (S )-MCPG non-selective group I/group II antagonist 0337
      1827 Group II mGlu Receptor Tocriset™ (2R ,4R)-APDC selective group II agonist 1208
      DCG IV potent, selective group II agonist 0975
      LY 341495 potent group II/group III antagonist 1209
      EGLU selective group II antagonist 0971
      (S )-MCPG non-selective group I/group II antagonist 0337
      1828 Group III mGlu Receptor Tocriset™ L-AP4 selective group III mGlu agonist 0103
      (RS)-PPG potent, selective group III agonist 1220
      CPPG potent group III antagonist 0972
      MSOP specific group III antagonist 0803
      LY 341495 potent group II/group III antagonist 1209
      1829 Mixed mGlu Receptor Tocriset™ (S)-3,5-DHPG specific group I mGlu agonist 0805
      DCG IV potent, selective group II agonist 0975
      L-AP4 selective group III mGlu agonist 0103
      (S )-MCPG non-selective group I/group II antagonist 0337
      LY 341495 potent group II/group III antagonist 1209
      Excitatory Amino Acid Uptake Inhibitors
      1830 Excitatory Amino Acid Transporter Inhibitor Tocriset™ L-(-)-threo-3-Hydroxyaspartic acid transportable EAAT1-4 inhibitor/non-transportable EAAT5 inhibitor 0183
      L-trans-2,4-PDC transportable EAAT1-4 inhibitor/non-transportable EAAT5 inhibitor 0298
      DL-TBOA potent non-transportable inhibitor of EAATs 1223
      Dihydrokainic acid EAAT2-selective non-transportable inhibitor 0111
      SYM 2081 EAAT2 inhibitor 0903
    • Adrenergics
      Cat. No. Product Components
      Name Function Cat. No.
      1871 α1-Adrenoceptor Tocriset™ A 61603 hydrobromide α1A-adrenoceptor agonist 1052
      Cirazoline hydrochloride selective α1-adrenoceptor agonist 0888
      BMY 7378 dihydrochloride selective α1D-adrenoceptor antagonist 1006
      WB 4101 hydrochloride selective α1A-adrenoceptor antagonist 0946
      Prazosin hydrochloride α1-adrenoceptor antagonist 0623
      1872 α2-Adrenoceptor Tocriset™ Guanfacine hydrochloride selective α2A-adrenoceptor agonist 1030
      UK 14,304 α2-adrenoceptor agonist 0425
      ARC 239 dihydrochloride selective α2B-adrenoceptor antagonist 0928
      BRL 44408 maleate selective α2A-adrenoceptor antagonist 1133
      Rauwolscine hydrochloride standard α2-adrenoceptor antagonist 0891
      1873 β-Adrenoceptor Agonist Tocriset™ BRL 37344, sodium salt selective β3-adrenoceptor agonist 0948
      Isoproterenol hydrochloride standard β-adrenoceptor agonist 1747
      Salmeterol selective β2-adrenoceptor agonist 1660
      1874 β-Adrenoceptor Antagonist Tocriset™ CGP 20712 dihydrochloride potent, selective β1-adrenoceptor antagonist 1024
      ICI 118,551 hydrochloride selective β2-adrenoceptor antagonist 0821
      SR 59230A hydrochloride potent, selective b3-adrenoceptor antagonist 1511
      1875 Mixed Adrenergic Tocriset™ Cirazoline hydrochloride selective α1-adrenoceptor agonist 0888
      UK 14,304 α2-adrenoceptor agonist 0425
      Isoproterenol hydrochloride standard β-adrenoceptor agonist 1747
      Prazosin hydrochloride α1 and α2B-adrenoceptor antagonist 0623
      Sotalol hydrochloride b-adrenoceptor antagonist 0952
    • Histaminergics
      Cat. No. Product Components
      Name Function Cat. No.
      1876 Histamine H3 Receptor Tocriset™ Imetit dihydrobromide 0729
      (R)-(-)-a-Methylhistamine dihydrobromide 0569
      Clobenpropit dihydrobromide 0752
      Iodophenpropit dihydrobromide 0779
      Thioperamide maleate 0664
    • Serotonergics
      Cat. No. Product Components
      Name Function Cat. No.
      1877 Serotonin Uptake Inhibitor Tocriset™ 6-Nitroquipazine maleate potent 5-HT re-uptake inhibitor 0596
      Citalopram hydrobromide highly selective, potent 5-HT uptake inhibitor 1427
      Clomipramine hydrochloride potent, selective 5-HT uptake blocker 0457
      Fluoxetine hydrochloride selective 5-HT re-uptake inhibitor 0927
      Fluvoxamine maleate selective 5-HT re-uptake inhibitor 1033
    • Cannabinoids
      Cat. No. Product Components
      Name Function Cat. No.
      2178 Cannabinoid CB1 Receptor Tocriset™ ACEA potent, highly selective CB1 agonist 1319
      (R)-(+)-Methanandamide potent and selective CB1 agonist 1121
      AM 251 potent, selective CB1 antagonist 1117
      2179 Cannabinoid Receptor Agonist Tocriset™ Anandamide endogenous CB receptor agonist 1339
      2-Arachidonylglycerol endogenous cannabinoid agonist 1298
      CP 55,940 potent CB1 and CB2 agonist 0949
      HU 210 highly potent cannabinoid agonist 0966
      WIN 55,212-2 mesylate highly potent cannabinoid agonist 1038
      2180 Endocannabinoid Tocriset™ Anandamide endogenous CB receptor agonist 1339
      NADA endogenous CB1 agonist 1568
      Noladin ether endogenous agonist for CB1 1411
      Virodhamine endogenous CB1 partial agonist/antagonist, CB2 agonist 1569
    • Vanilloids
      Cat. No. Product Components
      Name Function Cat. No.
      2181 Vanilloid TRPV1 Receptor Tocriset™ (E)-Capsaicin prototypic vanilloid receptor agonist 0462
      Olvanil potent vanilloid receptor agonist 0934
      Resiniferatoxin ultrapotent vanilloid receptor agonist 1137
      Capsazepine vanilloid receptor antagonist 0464
      SB 366791 potent, selective, competitive VR1 antagonist 1615